Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00611351 · OUTCOME

Incidence of Grade II-IV Acute Graft-versus-host-disease (GVHD)

Busulfan, Cyclophosphamide, & Antithymocyte Globulin Followed by Stem Cell Transplant in Treating Hematologic Cancer · Source last updated 2023-10-23

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
COUNT_OF_PARTICIPANTS
Unit
Participants
Interval / dispersion
Not reported
Time frame
at day 100 post transplantation

Analysis population: count of participants represents number of participants with documented acute GVHD prior to day 100 post transplant.

Groups in this outcome

Unrelated Donor Allogeneic

Matched unrelated donor allogeneic stem cell transplantation with a conditioning regimen of targeted busulfan, cyclophosphamide and thymoglobulin.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Unrelated Donor Allogeneic5

Reported measurements

Source class 1
Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Unrelated Donor Allogeneic4Not reportedNot reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        4
denoms
  1. counts
    1. group Id
      OG000
      value
      5
    units
    Participants
groups
  1. description
    Matched unrelated donor allogeneic stem cell transplantation with a conditioning regimen of targeted busulfan, cyclophosphamide and thymoglobulin.
    id
    OG000
    title
    Unrelated Donor Allogeneic
param Type
COUNT_OF_PARTICIPANTS
population Description
count of participants represents number of participants with documented acute GVHD prior to day 100 post transplant.
reporting Status
POSTED
time Frame
at day 100 post transplantation
title
Incidence of Grade II-IV Acute Graft-versus-host-disease (GVHD)
type
SECONDARY
unit Of Measure
Participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice